Search Results - "Zanchetta, Katarína"

Effectiveness, Adverse Events, and Immune Response Following Double Vaccination with BNT162b2 in Staff at the National Comprehensive Cancer Center (NCCC) by Palacka, Patrik, Pol'anová, Monika, Svobodová, Alena, Žigmond, Jan, Zanchetta, Katarína, Gombárová, Vlasta, Vulganová, Martina, Slopovský, Ján, Obertová, Jana, Drgoňa, Ľuboš, Mego, Michal, Pechan, Juraj

“…Vaccination remains the leading strategy against COVID-19 worldwide. BNT162b2 is among the first licensed vaccines with high effectiveness. However, the role…”
Get full text

Incidence of tozinameran adverse events among the employees of National Cancer Institute by Palacka, Patrik, Slopovsky, Jan, Zanchetta, Katarina, Drgona, Lubos, Badurikova, Eva, Bernadicova, Beata, Baranova, Vladimira, Pechan, Juraj, Mego, Michal

“…Abstract only e18724 Background: Active immunization seems to be the most effective protection against COVID-19. The objective of this prospective study was to…”
Get full text

Antibodies and cell immunity after vaccination with tozinameran (BNT162b2) in workers of National Comprehensive Cancer Center (NCCC) in Slovakia by Palacka, Patrik, Polanova, Monika, Svobodova, Alena, Zigmond, Jan, Zanchetta, Katarina, Gombarova, Vlasta, Vulganova, Martina, Slopovsky, Jan, Obertova, Jana, Mego, Michal, Drgona, Lubos, Pechan, Juraj

“…e18774 Background: Vaccination remains the leading strategy against Covid-19 worldwide. BNT 162b2 (tozinameran) belongs among first licensed vaccines with good…”
Get full text